Which blood collection tube should be filled first, the gold‑top serum separator tube (SST) or the lavender EDTA tube?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Order of Blood Tube Collection: Gold SST Before Lavender EDTA

Fill the gold-top serum separator tube (SST) before the lavender EDTA tube to prevent cross-contamination of EDTA anticoagulant into serum specimens, which can falsely alter critical electrolyte results.

The Standard Order of Draw

The recommended sequence for blood collection follows a specific protocol designed to minimize additive carryover between tubes 1:

  1. Blood culture tubes (if needed)
  2. Citrated coagulation tubes (light blue top)
  3. Serum tubes (red, gold, or tiger tops/SST) ← Draw FIRST between your two options
  4. Heparin tubes (green tops)
  5. EDTA tubes (lavender tops) ← Draw SECOND between your two options
  6. PAXgene or Tempus tubes (for RNA/miRNA)

Why This Order Matters

Risk of EDTA Contamination

When you draw the lavender EDTA tube first, residual EDTA can contaminate subsequent tubes through:

  • Needle carryover in closed vacuum systems
  • Backflow during collection
  • Transfer contamination in syringe collection methods

Clinical Impact of EDTA Carryover

Even small amounts of EDTA contamination significantly alter test results 2:

  • Magnesium, calcium, and potassium are altered by K3EDTA whole-blood contamination
  • Iron values change at EDTA concentrations of 4.4 mmol/L
  • Contamination with just 1 μL of pure K3EDTA solution can affect results
  • An absolute volume larger than 10 μL of EDTA whole blood is necessary to alter most test results

Key Practical Points

The Evidence on Carryover Risk

Research demonstrates that EDTA carryover in closed vacuum systems is "highly unlikely" when following proper technique 2. However, the consequences of contamination—particularly for electrolytes like calcium, magnesium, and potassium—are clinically significant enough to warrant strict adherence to the order of draw.

Common Pitfalls to Avoid

  • Never reverse the order even when you think you're being careful—the risk isn't worth it
  • Discard the first 1-2 mL when drawing from an IV line to clear any contaminants from tubing
  • Document your collection method as variations in venous access can affect results 1
  • With syringe collection, slight EDTA carryover can occur even without biomarker alteration 2

Tube Performance Considerations

The gold SST demonstrates 3:

  • High correlation and comparable stability to standard serum tubes
  • Suitable for rapid testing as an alternative
  • Clinically comparable differences across most analytes

The lavender EDTA tube is versatile for downstream analyses 1:

  • Suitable for genomics, proteomics, and metabolomics
  • Less likely to interfere with analyte detection compared to other anticoagulants
  • Can be processed to yield plasma, RBCs, and buffy coat components

Bottom Line Algorithm

Always follow this sequence:

  1. Draw gold SST first
  2. Draw lavender EDTA second
  3. If using IV access, discard first 1-2 mL before filling any tubes
  4. Use closed vacuum system when possible to minimize contamination risk

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.